Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy.
Monoclonal antibody therapy.
Principal Investigator
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Monoclonal antibody therapy.
Monoclonal antibody therapy. Front Biosci. 2006 May 01; 11:1620-35.
View in:
PubMed
subject areas
Alemtuzumab
Aminoglycosides
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Antibodies, Neoplasm
Antineoplastic Agents
Bevacizumab
Cetuximab
Clinical Trials as Topic
Hematologic Neoplasms
Humans
Immunotherapy
Immunotoxins
Neoplasms
Rituximab
Signal Transduction
Trastuzumab
authors with profiles
Michael Bishop